2018-2023 Global Biotherapeutics Cell Line Consumption Market Report
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Biotherapeutics Cell Line market for 2018-2023.
The biocellular therapy industry includes upstream cell storage, midstream cell technology development, and downstream cell therapy.
The downstream of the biological cell therapy industry chain - cell therapy, the implementation of the main body is the top three hospitals; there are two types of downstream industry models: one for the top three hospitals to carry out this business, the other for the top three hospitals and enterprises cooperation, the company provides Technical services and technical support, the hospital provides a clinical platform to implement treatment behavior.
Over the next five years, LPI(LP Information) projects that Biotherapeutics Cell Line will register a 7.8% CAGR in terms of revenue, reach US$ 88 million by 2023, from US$ 56 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Biotherapeutics Cell Line market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Single Cell Cloning
Transfection and Selection
Segmentation by application:
Cancer
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Becton Dickinson
Beckman Coulter
Boehringer Ingelheim Pharma
CMC Biologics
Catalent
Lonza Group
ProBioGen
Partec
SAFC
Sony Biotechnology
Selexis
Thermo Fisher Scientific
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Biotherapeutics Cell Line consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Biotherapeutics Cell Line market by identifying its various subsegments.
Focuses on the key global Biotherapeutics Cell Line manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Biotherapeutics Cell Line with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Biotherapeutics Cell Line submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2018-2023 Global Biotherapeutics Cell Line Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biotherapeutics Cell Line Consumption 2013-2023
2.1.2 Biotherapeutics Cell Line Consumption CAGR by Region
2.2 Biotherapeutics Cell Line Segment by Type
2.2.1 Single Cell Cloning
2.2.2 Transfection and Selection
2.3 Biotherapeutics Cell Line Consumption by Type
2.3.1 Global Biotherapeutics Cell Line Consumption Market Share by Type (2013-2018)
2.3.2 Global Biotherapeutics Cell Line Revenue and Market Share by Type (2013-2018)
2.3.3 Global Biotherapeutics Cell Line Sale Price by Type (2013-2018)
2.4 Biotherapeutics Cell Line Segment by Application
2.4.1 Cancer
2.4.2 Other
2.5 Biotherapeutics Cell Line Consumption by Application
2.5.1 Global Biotherapeutics Cell Line Consumption Market Share by Application (2013-2018)
2.5.2 Global Biotherapeutics Cell Line Value and Market Share by Application (2013-2018)
2.5.3 Global Biotherapeutics Cell Line Sale Price by Application (2013-2018)
3 Global Biotherapeutics Cell Line by Players
3.1 Global Biotherapeutics Cell Line Sales Market Share by Players
3.1.1 Global Biotherapeutics Cell Line Sales by Players (2016-2018)
3.1.2 Global Biotherapeutics Cell Line Sales Market Share by Players (2016-2018)
3.2 Global Biotherapeutics Cell Line Revenue Market Share by Players
3.2.1 Global Biotherapeutics Cell Line Revenue by Players (2016-2018)
3.2.2 Global Biotherapeutics Cell Line Revenue Market Share by Players (2016-2018)
3.3 Global Biotherapeutics Cell Line Sale Price by Players
3.4 Global Biotherapeutics Cell Line Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Biotherapeutics Cell Line Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Biotherapeutics Cell Line Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Biotherapeutics Cell Line by Regions
4.1 Biotherapeutics Cell Line by Regions
4.1.1 Global Biotherapeutics Cell Line Consumption by Regions
4.1.2 Global Biotherapeutics Cell Line Value by Regions
4.2 Americas Biotherapeutics Cell Line Consumption Growth
4.3 APAC Biotherapeutics Cell Line Consumption Growth
4.4 Europe Biotherapeutics Cell Line Consumption Growth
4.5 Middle East & Africa Biotherapeutics Cell Line Consumption Growth
5 Americas
5.1 Americas Biotherapeutics Cell Line Consumption by Countries
5.1.1 Americas Biotherapeutics Cell Line Consumption by Countries (2013-2018)
5.1.2 Americas Biotherapeutics Cell Line Value by Countries (2013-2018)
5.2 Americas Biotherapeutics Cell Line Consumption by Type
5.3 Americas Biotherapeutics Cell Line Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Biotherapeutics Cell Line Consumption by Countries
6.1.1 APAC Biotherapeutics Cell Line Consumption by Countries (2013-2018)
6.1.2 APAC Biotherapeutics Cell Line Value by Countries (2013-2018)
6.2 APAC Biotherapeutics Cell Line Consumption by Type
6.3 APAC Biotherapeutics Cell Line Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Biotherapeutics Cell Line by Countries
7.1.1 Europe Biotherapeutics Cell Line Consumption by Countries (2013-2018)
7.1.2 Europe Biotherapeutics Cell Line Value by Countries (2013-2018)
7.2 Europe Biotherapeutics Cell Line Consumption by Type
7.3 Europe Biotherapeutics Cell Line Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Biotherapeutics Cell Line by Countries
8.1.1 Middle East & Africa Biotherapeutics Cell Line Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Biotherapeutics Cell Line Value by Countries (2013-2018)
8.2 Middle East & Africa Biotherapeutics Cell Line Consumption by Type
8.3 Middle East & Africa Biotherapeutics Cell Line Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Biotherapeutics Cell Line Distributors
10.3 Biotherapeutics Cell Line Customer
11 Global Biotherapeutics Cell Line Market Forecast
11.1 Global Biotherapeutics Cell Line Consumption Forecast (2018-2023)
11.2 Global Biotherapeutics Cell Line Forecast by Regions
11.2.1 Global Biotherapeutics Cell Line Forecast by Regions (2018-2023)
11.2.2 Global Biotherapeutics Cell Line Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Biotherapeutics Cell Line Forecast by Type
11.8 Global Biotherapeutics Cell Line Forecast by Application
12 Key Players Analysis
12.1 Becton Dickinson
12.1.1 Company Details
12.1.2 Biotherapeutics Cell Line Product Offered
12.1.3 Becton Dickinson Biotherapeutics Cell Line Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Becton Dickinson News
12.2 Beckman Coulter
12.2.1 Company Details
12.2.2 Biotherapeutics Cell Line Product Offered
12.2.3 Beckman Coulter Biotherapeutics Cell Line Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Beckman Coulter News
12.3 Boehringer Ingelheim Pharma
12.3.1 Company Details
12.3.2 Biotherapeutics Cell Line Product Offered
12.3.3 Boehringer Ingelheim Pharma Biotherapeutics Cell Line Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Boehringer Ingelheim Pharma News
12.4 CMC Biologics
12.4.1 Company Details
12.4.2 Biotherapeutics Cell Line Product Offered
12.4.3 CMC Biologics Biotherapeutics Cell Line Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 CMC Biologics News
12.5 Catalent
12.5.1 Company Details
12.5.2 Biotherapeutics Cell Line Product Offered
12.5.3 Catalent Biotherapeutics Cell Line Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Catalent News
12.6 Lonza Group
12.6.1 Company Details
12.6.2 Biotherapeutics Cell Line Product Offered
12.6.3 Lonza Group Biotherapeutics Cell Line Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Lonza Group News
12.7 ProBioGen
12.7.1 Company Details
12.7.2 Biotherapeutics Cell Line Product Offered
12.7.3 ProBioGen Biotherapeutics Cell Line Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 ProBioGen News
12.8 Partec
12.8.1 Company Details
12.8.2 Biotherapeutics Cell Line Product Offered
12.8.3 Partec Biotherapeutics Cell Line Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Partec News
12.9 SAFC
12.9.1 Company Details
12.9.2 Biotherapeutics Cell Line Product Offered
12.9.3 SAFC Biotherapeutics Cell Line Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 SAFC News
12.10 Sony Biotechnology
12.10.1 Company Details
12.10.2 Biotherapeutics Cell Line Product Offered
12.10.3 Sony Biotechnology Biotherapeutics Cell Line Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Sony Biotechnology News
12.11 Selexis
12.12 Thermo Fisher Scientific
13 Research Findings and Conclusion
